DK396188A - Ikke-vandig oploesning af doxorubicinhydrochlorid - Google Patents

Ikke-vandig oploesning af doxorubicinhydrochlorid

Info

Publication number
DK396188A
DK396188A DK396188A DK396188A DK396188A DK 396188 A DK396188 A DK 396188A DK 396188 A DK396188 A DK 396188A DK 396188 A DK396188 A DK 396188A DK 396188 A DK396188 A DK 396188A
Authority
DK
Denmark
Prior art keywords
aqueous
aqueous solution
water
doxorubicin hydrochloride
solutions
Prior art date
Application number
DK396188A
Other languages
English (en)
Other versions
DK396188D0 (da
Inventor
Murray Arthur Kaplan
Joseph Ballard Bogardus
Robert Kevin Perrone
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK396188D0 publication Critical patent/DK396188D0/da
Publication of DK396188A publication Critical patent/DK396188A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK396188A 1987-07-16 1988-07-15 Ikke-vandig oploesning af doxorubicinhydrochlorid DK396188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7418987A 1987-07-16 1987-07-16

Publications (2)

Publication Number Publication Date
DK396188D0 DK396188D0 (da) 1988-07-15
DK396188A true DK396188A (da) 1989-01-17

Family

ID=22118210

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396188A DK396188A (da) 1987-07-16 1988-07-15 Ikke-vandig oploesning af doxorubicinhydrochlorid

Country Status (11)

Country Link
EP (1) EP0299528B1 (da)
JP (1) JPS6438021A (da)
KR (1) KR920004096B1 (da)
AT (1) ATE82682T1 (da)
AU (1) AU615454B2 (da)
DE (1) DE3876160T2 (da)
DK (1) DK396188A (da)
ES (1) ES2052646T3 (da)
FI (1) FI883337A (da)
GR (1) GR3006383T3 (da)
PT (1) PT88015B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372889B1 (en) * 1988-12-05 1993-03-24 Bristol-Myers Squibb Company Doxorubicin solutions
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
RU2065307C1 (ru) * 1994-12-13 1996-08-20 Александр Васильевич Тихонов Способ лечения первичного рака печени и набор для лечения первичного рака печени
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5946961A (en) * 1998-05-01 1999-09-07 Buhrke Industries, Inc. Web bowing apparatus
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
EP2879660A1 (de) * 2012-08-03 2015-06-10 Mestex AG Resiniferatoxin-lösung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529422B2 (en) * 1978-10-20 1983-06-09 Eli Lilly And Company Stable erythromycin solution
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
DE3876160T2 (de) 1993-04-01
DE3876160D1 (de) 1993-01-07
ATE82682T1 (de) 1992-12-15
EP0299528A1 (en) 1989-01-18
JPS6438021A (en) 1989-02-08
PT88015B (pt) 1995-03-01
GR3006383T3 (da) 1993-06-21
FI883337A0 (fi) 1988-07-13
AU615454B2 (en) 1991-10-03
JPH0559093B2 (da) 1993-08-30
KR920004096B1 (ko) 1992-05-25
DK396188D0 (da) 1988-07-15
EP0299528B1 (en) 1992-11-25
PT88015A (pt) 1989-06-30
KR890001570A (ko) 1989-03-27
FI883337A (fi) 1989-01-17
AU1905188A (en) 1989-01-19
ES2052646T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
NO173365C (no) Fremgangsm}te for fremstilling av et i det vesentlige ikke-sviende, vandig, antiinflammatorisk steroidpreparat egnet for intranasal administerering
FI864974A0 (fi) Vaetskeformiga sanitetsrengoerings- och avkalkningsmedel samt foerfarande foer deras framstaellning.
DK396188D0 (da) Ikke-vandig oploesning af doxorubicinhydrochlorid
DK396288A (da) Vandige oploesninger af doxorubicin, hydrochlorid
FI885041A0 (fi) Foerfarande foer producering av foermaonliga, poroesa och absorbenta papperssubstrat och liknande som successivt belagts med barriaeraemne och silikon i samma framstaellningslinje (in-line) samt produkter som framstaellts med foerfarandet.
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
IT1250410B (it) Composti steroidei attivi sul sistema cardiovascolare
NO903058D0 (no) Farmasoeytisk preparat med forbedret absorberbarhet.
ATE87210T1 (de) Doxorubicin-loesungen.
JPS51144735A (en) A remedy for hepatic failure
JPS51144733A (en) A remedy for hepatic failure
JPS51144732A (en) A remedy for hepatic failure
JPS523391A (en) Mount used for semiconductor laser
IT8421980V0 (it) Struttura di resistenza a telaio, presentante un sistema perfezionato di ritegno delle lamelle isolanti, su una o piu' pareti del telaio stesso.
LIPSETT et al. Temporal coherence between superposed light beams from two ruby optical masers(Transient coherence of superposed beams from two ruby lasers for periods of same order as spike widths)
JPS52143221A (en) Novel preparations for rectal administration
FI49719C (fi) Menetelmä kemoterapeuttisesti vaikuttavien amidiini-typpiatomiin subst ituoitujen 2-metyyli-3-amidino-kinoksaliini-di-N-oksidien-(1,4) valmis tamiseksi.
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
RO103864A2 (en) Anti-herpetic unguent
CA2048856A1 (en) 15-deoxyspergualin suppository
IT1262931B (it) Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment